Stocks and Investing
Stocks and Investing
Fri, May 6, 2016
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Thu, May 5, 2016
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Wed, May 4, 2016
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Vamil Divan Initiated (TEVA) at Hold and Held Target at $60 on, May 4th, 2016
Vamil Divan of Credit Suisse, Initiated "Teva Pharmaceutical Industries Limited" (TEVA) at Hold and Held Target at $60 on, May 4th, 2016.
Vamil has made no other calls on TEVA in the last 4 months.
There are 3 other peers that have a rating on TEVA. Out of the 3 peers that are also analyzing TEVA, 0 agree with Vamil's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Vamil
- David Risinger of "Morgan Stanley" Maintained at Buy with Decreased Target to $69 on, Tuesday, May 3rd, 2016
- Jacob Hughes of "Wells Fargo" Initiated at Buy on, Friday, February 19th, 2016
- Gregg Gilbert of "Deutsche Bank" Maintained at Strong Buy with Decreased Target to $80 on, Friday, February 12th, 2016
Contributing Sources